Finland· FI-REL-REL48866
Lomir Sro
A isradipine product containing isradipine, registered in Finland by Orifarm Oy. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Isradipine is registered in 5 of 19 countries.
Countries holding a registration under ATC C08CA03 (isradipine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Isradipine · ATC C08CA03
5 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of isradipine costs, country by country.
Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Isradipine · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- US United States$1.99 (acquisition cost)
The record
At a glance
Fimea (Finland)- Active substance
- Isradipine
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- C08CA03
- ATC class
- Isradipine
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
283 interactions on record for isradipine.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isradipine · interactions on record
283 records
- 8 severe
- 171 moderate
- 2 minor
- 55 info
Most severe, free to view
- DolasetronA04AA04severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
- MitotaneL01XX23severe
47 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Isradipine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumLomir Retard 5 mgSankyo Pharma Belgium
- FranceICAZ LP 5 mg, gélule à libération prolongéeFARMACEUTICO SIT
- United KingdomIsradipine 2.5mg tabletsA A H Pharmaceuticals Ltd
- United StatesIsradipineAvKARE
- ItalyCLIVOTEN*14 cps 5 mg rilascio prolungatoITALFARMACO SpA
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- France · Icaz Lp
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3957e2d6-a655-420c-bdc5-e7ae172225da GET /v1/drugs/3957e2d6-a655-420c-bdc5-e7ae172225da?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "5",
"form": "depotkapseli, kova",
"route": null,
"ddd_unit": "mg",
"strength": "5 mg",
"atc_label": "isradipiini",
"ma_number": "34058",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL48866",
"authorised_at": "2016-05-04"
}See everything about isradipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.